timothy sykes logo

Stock News

Neuronetics Beats Expectations with Strong Q4 Revenue and Cash Flow

Jack KelloggAvatar
Written by Jack Kellogg Reviewed by Ellis Hobbs Fact-checked by Matt Monaco
Updated 2/11/2026, 9:19 am ET 2/11/2026, 9:19 am ET | 4 min 4 min read
Neuronetics Beats Expectations with Strong Q4 Revenue and Cash Flow Thumbnail

Neuronetics Inc. stocks have been trading up by 27.37 percent following optimistic responses to their recent strategic decisions.

Candlestick Chart

Live Update At 09:18:42 EST: On Wednesday, February 11, 2026 Neuronetics Inc. stock [NASDAQ: STIM] is trending up by 27.37%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

Neuronetics has unveiled preliminary financial results, showcasing impressive strides in revenue and cash flow. For Q4 2025, the company generated $41.8 million in revenue, outperforming the consensus of $40.66 million. This represents a notable increase from prior periods and reflects a strengthened cash position with $0.9 million of positive operational cash flow.

For the fiscal year 2025, the projected revenue stands at $149.2 million, slightly above the forecasted $148.08 million. The year-end cash position is $34.1M, signaling an enhanced financial footing to support future growth opportunities.

When dissecting the performance, it’s apparent that the Q4 revenue exhibited considerable growth from last year’s $22.5M to current results. This strong performance also extended across the fiscal year, with revenue doubling from $74.9M in 2024. Such achievements stem from operational efficiency, increased demand, and successful product innovation.

Competitive Pressures Mount

Facing stiff competition within the healthcare industry, Neuronetics’ financial report highlights a keen focus on operational and strategic growth. This long-standing market player has leveraged its experience to outshine competitors, evident in the solid revenue figures and profitability efforts reflected in its recent financial disclosures. As of 2025, Neuronetics is not just surviving but thriving in an industry subject to rapid technological evolution and market shifts.

Neuronetics’ strides are emphasized by key metrics like a gross margin of 50.4%, despite negative profitability margins. Operating with a commendable revenue per share, the company’s enterprise value is pegged at $164.65M, and a price-to-sales ratio of 0.79 shows that market valuation remains intriguing to investors and market analysts alike.

More Breaking News

Conclusion

Neuronetics’ preliminary results spell a promising trajectory, reinforcing trader confidence and market trust. Surpassing revenue expectations and achieving positive cash flow paint a hopeful picture for strategic acquisitions or expansions moving forward. This impressive performance underscores its resilience and potential to navigate the dynamic market landscape effectively.

Moreover, as financial strength grows steadily, Neuronetics is strategically positioned to leverage future innovations and collaborations. As market confidence rises alongside these impressive figures, stakeholders continue their close watch on Neuronetics’ unfolding story—anticipating upcoming strategic maneuvers and sustained growth.

The notable preliminary figures ignite greater curiosity and a heightened sense of optimism among stakeholders. As millionaire penny stock trader and teacher Tim Sykes says, “It’s better to go home at zero than to go home in the red.” As the market continues to receive these developments with admiration, Neuronetics remains a focal point for growth and trading assessments in the healthcare and financial sectors.

This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Our content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to us for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize our news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities.

Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles:

Once you’ve got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market’s twists and turns.
Dig into StocksToTrade’s watchlists here:

How much has this post helped you?

(0 votes, average: 0 out of 5)
Leave a reply
Author card Timothy Sykes picture

Jack Kellogg

He teaches webinars on Tim Sykes’ Trading Challenge He became Tim’s youngest millionaire student in 2020. Now he’s second on the Trading Challenge leaderboard with $12.9 million in career earnings. He’s a master of the 7-Step Pennystocking Framework. Jack is one of a rare breed of traders to profitably trade the entire penny stock framework.
Read More

* Results are not typical and will vary from person to person. Making money trading stocks takes time, dedication, and hard work. There are inherent risks involved with investing in the stock market, including the loss of your investment. Past performance in the market is not indicative of future results. Any investment is at your own risk. See Terms of Service here

The available research on day trading suggests that most active traders lose money. Fees and overtrading are major contributors to these losses.

A 2000 study called “Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors” evaluated 66,465 U.S. households that held stocks from 1991 to 1996. The households that traded most averaged an 11.4% annual return during a period where the overall market gained 17.9%. These lower returns were attributed to overconfidence.

A 2014 paper (revised 2019) titled “Learning Fast or Slow?” analyzed the complete transaction history of the Taiwan Stock Exchange between 1992 and 2006. It looked at the ongoing performance of day traders in this sample, and found that 97% of day traders can expect to lose money from trading, and more than 90% of all day trading volume can be traced to investors who predictably lose money. Additionally, it tied the behavior of gamblers and drivers who get more speeding tickets to overtrading, and cited studies showing that legalized gambling has an inverse effect on trading volume.

A 2019 research study (revised 2020) called “Day Trading for a Living?” observed 19,646 Brazilian futures contract traders who started day trading from 2013 to 2015, and recorded two years of their trading activity. The study authors found that 97% of traders with more than 300 days actively trading lost money, and only 1.1% earned more than the Brazilian minimum wage ($16 USD per day). They hypothesized that the greater returns shown in previous studies did not differentiate between frequent day traders and those who traded rarely, and that more frequent trading activity decreases the chance of profitability.

These studies show the wide variance of the available data on day trading profitability. One thing that seems clear from the research is that most day traders lose money .

Millionaire Media 66 W Flagler St. Ste. 900 Miami, FL 33130 United States (888) 878-3621 This is for information purposes only as Millionaire Media LLC nor Timothy Sykes is registered as a securities broker-dealer or an investment adviser. No information herein is intended as securities brokerage, investment, tax, accounting or legal advice, as an offer or solicitation of an offer to sell or buy, or as an endorsement, recommendation or sponsorship of any company, security or fund. Millionaire Media LLC and Timothy Sykes cannot and does not assess, verify or guarantee the adequacy, accuracy or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. Millionaire Media LLC and Timothy Sykes in no way warrants the solvency, financial condition, or investment advisability of any of the securities mentioned in communications or websites. In addition, Millionaire Media LLC and Timothy Sykes accepts no liability whatsoever for any direct or consequential loss arising from any use of this information. This information is not intended to be used as the sole basis of any investment decision, nor should it be construed as advice designed to meet the investment needs of any particular investor. Past performance is not necessarily indicative of future returns.

Citations for Disclaimer

Barber, Brad M. and Odean, Terrance, Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors. Available at SSRN: “Day Trading for a Living?”

Barber, Brad M. and Lee, Yi-Tsung and Liu, Yu-Jane and Odean, Terrance and Zhang, Ke, Learning Fast or Slow? (May 28, 2019). Forthcoming: Review of Asset Pricing Studies, Available at SSRN: “https://ssrn.com/abstract=2535636”

Chague, Fernando and De-Losso, Rodrigo and Giovannetti, Bruno, Day Trading for a Living? (June 11, 2020). Available at SSRN: “https://ssrn.com/abstract=3423101”